Vaccinex (VCNX) Competitors $2.55 -0.27 (-9.57%) (As of 10/4/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends VCNX vs. CPIX, AKTX, BTAI, CYTH, BFRG, SHPH, ALTS, PIRS, VINC, and SONNShould you be buying Vaccinex stock or one of its competitors? The main competitors of Vaccinex include Cumberland Pharmaceuticals (CPIX), Akari Therapeutics (AKTX), BioXcel Therapeutics (BTAI), Cyclo Therapeutics (CYTH), Bullfrog AI (BFRG), Shuttle Pharmaceuticals (SHPH), Janone (ALTS), Pieris Pharmaceuticals (PIRS), Vincerx Pharma (VINC), and Sonnet BioTherapeutics (SONN). Vaccinex vs. Cumberland Pharmaceuticals Akari Therapeutics BioXcel Therapeutics Cyclo Therapeutics Bullfrog AI Shuttle Pharmaceuticals Janone Pieris Pharmaceuticals Vincerx Pharma Sonnet BioTherapeutics Vaccinex (NASDAQ:VCNX) and Cumberland Pharmaceuticals (NASDAQ:CPIX) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, media sentiment, community ranking, dividends, valuation and earnings. Is VCNX or CPIX more profitable? Vaccinex has a net margin of 0.00% compared to Cumberland Pharmaceuticals' net margin of -27.45%. Vaccinex's return on equity of 0.00% beat Cumberland Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets VaccinexN/A N/A -446.07% Cumberland Pharmaceuticals -27.45%-6.86%-2.46% Do analysts recommend VCNX or CPIX? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vaccinex 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/ACumberland Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Which has higher earnings and valuation, VCNX or CPIX? Cumberland Pharmaceuticals has higher revenue and earnings than Vaccinex. Cumberland Pharmaceuticals is trading at a lower price-to-earnings ratio than Vaccinex, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVaccinex$356K11.35-$20.25M-$82.80-0.03Cumberland Pharmaceuticals$37.79M0.47-$6.28M-$0.59-2.12 Does the MarketBeat Community favor VCNX or CPIX? Cumberland Pharmaceuticals received 64 more outperform votes than Vaccinex when rated by MarketBeat users. However, 60.00% of users gave Vaccinex an outperform vote while only 43.19% of users gave Cumberland Pharmaceuticals an outperform vote. CompanyUnderperformOutperformVaccinexOutperform Votes12360.00% Underperform Votes8240.00% Cumberland PharmaceuticalsOutperform Votes18743.19% Underperform Votes24656.81% Does the media prefer VCNX or CPIX? In the previous week, Cumberland Pharmaceuticals had 26 more articles in the media than Vaccinex. MarketBeat recorded 26 mentions for Cumberland Pharmaceuticals and 0 mentions for Vaccinex. Vaccinex's average media sentiment score of 0.00 beat Cumberland Pharmaceuticals' score of -0.09 indicating that Vaccinex is being referred to more favorably in the media. Company Overall Sentiment Vaccinex Neutral Cumberland Pharmaceuticals Neutral Do institutionals & insiders have more ownership in VCNX or CPIX? 50.1% of Vaccinex shares are held by institutional investors. Comparatively, 15.5% of Cumberland Pharmaceuticals shares are held by institutional investors. 51.5% of Vaccinex shares are held by insiders. Comparatively, 43.3% of Cumberland Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has more volatility and risk, VCNX or CPIX? Vaccinex has a beta of 0.96, meaning that its stock price is 4% less volatile than the S&P 500. Comparatively, Cumberland Pharmaceuticals has a beta of 0.2, meaning that its stock price is 80% less volatile than the S&P 500. SummaryVaccinex beats Cumberland Pharmaceuticals on 9 of the 15 factors compared between the two stocks. Ad Crypto 101 MediaThis Crypto Is Set to Explode in SeptemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Get Vaccinex News Delivered to You Automatically Sign up to receive the latest news and ratings for VCNX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VCNX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat are MarkeBeat Followers?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VCNX vs. The Competition Export to ExcelMetricVaccinexPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.04M$7.17B$5.50B$8.46BDividend YieldN/A7.85%4.92%4.12%P/E Ratio-0.0318.89104.9218.62Price / Sales11.35350.891,166.9583.66Price / CashN/A39.0640.3533.53Price / Book-0.985.864.944.56Net Income-$20.25M$151.48M$117.09M$225.49M7 Day Performance-24.11%6.59%3.04%2.51%1 Month Performance-54.71%25.48%17.94%14.33%1 Year Performance-83.44%18.83%24.05%20.36% Vaccinex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VCNXVaccinex1.0914 of 5 stars$2.55-9.6%N/A-77.8%$4.04M$356,000.00-0.0340Positive NewsGap UpHigh Trading VolumeCPIXCumberland Pharmaceuticals0.5973 of 5 stars$1.28+4.1%N/A-30.9%$18.16M$37.79M-2.1780Analyst ForecastHigh Trading VolumeAKTXAkari TherapeuticsN/A$2.95+0.3%N/A-17.4%$23.38MN/A0.009Analyst ForecastGap UpBTAIBioXcel Therapeutics4.1948 of 5 stars$0.61+1.7%$5.50+801.6%-77.8%$22.89M$2.40M-0.1290Negative NewsCYTHCyclo Therapeutics2.4751 of 5 stars$0.79+9.7%$0.95+20.4%-35.5%$22.58M$1.13M-0.799Gap DownBFRGBullfrog AI0.9385 of 5 stars$2.87-3.7%N/A-12.7%$22.53M$65,000.00-3.264News CoverageGap DownSHPHShuttle Pharmaceuticals0.278 of 5 stars$1.33+0.8%N/AN/A$22.34MN/A-2.895ALTSJanoneN/A$1.77-2.2%N/AN/A$22.28M$2.17M0.00170Positive NewsPIRSPieris Pharmaceuticals2.9253 of 5 stars$16.74+3.6%N/A-32.5%$22.10M$42.81M-1.40140News CoverageVINCVincerx Pharma0.6856 of 5 stars$0.72+4.4%N/A-26.1%$21.25MN/A-0.4060Positive NewsGap UpSONNSonnet BioTherapeutics1.9831 of 5 stars$6.71+845.1%$30.00+347.1%+105.2%$20.88M$55,881.000.0010Gap UpHigh Trading Volume Related Companies and Tools Related Companies: CPIX Competitors AKTX Competitors BTAI Competitors CYTH Competitors BFRG Competitors SHPH Competitors ALTS Competitors PIRS Competitors VINC Competitors SONN Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:VCNX) was last updated on 10/6/2024 by MarketBeat.com Staff From Our PartnersThe panic button has already been pressedIf you missed it, my emergency election broadcast is now available on replay.Porter & Company | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredAI Expert Reveals New PickEveryone’s talking about AI right now, but I’ve been talking about it for years. And now I’ve just released...Brownstone Research | SponsoredNo matter the outcome of the election, it could be a death sentence for your wealth...In today's financial landscape, many investors are feeling disillusioned and disappointed with traditional inv...Allegiance Gold | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredJeff Bezos Just Humiliated Elon MuskThe Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next...InvestorPlace | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaccinex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaccinex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
